Apellis Pharmaceuticals, Inc. (APLS) Social Stream
APELLIS PHARMACEUTICALS INC (APLS) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering APELLIS PHARMACEUTICALS INC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-10 | 12 | $116 | $28 | $68.307 | $66.09 | 3.35% |
| 2021-11-12 | 12 | $116 | $28 | $67.23 | $66.09 | 1.72% |
| 2021-11-17 | 11 | $116 | $28 | $67.692 | $66.09 | 2.42% |
| 2021-11-24 | 12 | $116 | $28 | $68.076 | $66.09 | 3% |
| 2021-11-29 | 12 | $116 | $28 | $67.615 | $66.09 | 2.31% |
| 2021-12-15 | 13 | $116 | $28 | $68.785 | $66.09 | 4.08% |
| 2022-01-05 | 13 | $116 | $28 | $69 | $66.09 | 4.4% |
| 2022-01-11 | 13 | $112 | $28 | $69.142 | $66.09 | 4.62% |
| 2022-01-26 | 13 | $112 | $34 | $69.571 | $66.09 | 5.27% |
| 2022-03-02 | 13 | $114 | $34 | $69.714 | $66.09 | 5.48% |
| 2022-03-16 | 13 | $114 | $34 | $69.5 | $66.09 | 5.16% |
| 2022-03-17 | 13 | $114 | $34 | $70.428 | $66.09 | 6.56% |
| 2022-03-22 | 13 | $114 | $34 | $70.071 | $66.09 | 6.02% |
| 2022-04-04 | 12 | $114 | $34 | $70.23 | $66.09 | 6.26% |
| 2022-04-14 | 12 | $114 | $34 | $70.23 | $66.09 | 6.26% |
| 2022-04-19 | 12 | $114 | $34 | $70.076 | $66.09 | 6.03% |
| 2022-04-21 | 12 | $114 | $34 | $70.307 | $66.09 | 6.38% |
| 2022-04-28 | 12 | $114 | $39 | $70.692 | $66.09 | 6.96% |
| 2022-05-10 | 12 | $102 | $40 | $69.923 | $66.09 | 5.8% |
| 2022-05-12 | 12 | $102 | $40 | $70.23 | $66.09 | 6.26% |
| 2022-06-01 | 13 | $102 | $40 | $70.384 | $66.09 | 6.5% |
| 2022-06-17 | 13 | $102 | $40 | $69.642 | $66.09 | 5.37% |
| 2022-07-25 | 13 | $102 | $40 | $72.266 | $66.09 | 9.34% |
| 2022-08-09 | 13 | $113 | $40 | $74.2 | $66.09 | 12.27% |
| 2022-08-13 | 13 | $113 | $40 | $74.333 | $66.09 | 12.47% |
| 2022-08-24 | 13 | $113 | $40 | $75.733 | $66.09 | 14.59% |
| 2022-09-06 | 13 | $113 | $40 | $76.4 | $66.09 | 15.6% |
| 2022-10-04 | 13 | $113 | $40 | $78.769 | $66.09 | 19.18% |
| 2022-10-17 | 13 | $113 | $40 | $78.153 | $66.09 | 18.25% |
| 2022-10-21 | 13 | $123 | $40 | $78.923 | $66.09 | 19.42% |
| 2022-11-04 | 13 | $123 | $40 | $78.692 | $66.09 | 19.07% |
| 2022-11-08 | 13 | $123 | $40 | $76.923 | $66.09 | 16.39% |
| 2022-11-10 | 13 | $123 | $40 | $74.615 | $66.09 | 12.9% |
| 2022-11-18 | 13 | $123 | $40 | $73.666 | $66.09 | 11.46% |
| 2023-01-03 | 13 | $123 | $40 | $72.461 | $66.09 | 9.64% |
| 2023-01-26 | 12 | $123 | $40 | $75.166 | $66.09 | 13.73% |
| 2023-02-16 | 12 | $123 | $40 | $74.916 | $66.09 | 13.35% |
| 2023-02-21 | 14 | $123 | $47 | $77.769 | $66.09 | 17.67% |
| 2023-02-22 | 14 | $123 | $51 | $84.142 | $66.09 | 27.31% |
| 2023-02-23 | 14 | $139 | $51 | $85.785 | $66.09 | 29.8% |
| 2023-02-24 | 14 | $139 | $51 | $85.5 | $66.09 | 29.37% |
| 2023-03-09 | 14 | $139 | $51 | $85.285 | $66.09 | 29.04% |
| 2023-03-13 | 14 | $139 | $51 | $85.428 | $66.09 | 29.26% |
| 2023-04-17 | 14 | $139 | $58 | $86.571 | $66.09 | 30.99% |
| 2023-04-24 | 14 | $141 | $58 | $89.357 | $66.09 | 35.21% |
| 2023-05-02 | 14 | $141 | $58 | $90.357 | $66.09 | 36.72% |
| 2023-05-05 | 14 | $141 | $58 | $91.285 | $66.09 | 38.12% |
| 2023-05-08 | 14 | $156 | $58 | $96.785 | $66.09 | 46.44% |
| 2023-05-09 | 14 | $156 | $76 | $104.142 | $66.09 | 57.58% |
| 2023-06-06 | 14 | $156 | $76 | $105 | $66.09 | 58.87% |
| 2023-07-17 | 14 | $156 | $76 | $105.785 | $66.09 | 60.06% |
| 2023-07-21 | 14 | $156 | $40 | $99.571 | $66.09 | 50.66% |
| 2023-07-31 | 14 | $156 | $40 | $95.714 | $66.09 | 44.82% |
| 2023-08-01 | 14 | $141 | $32 | $85.071 | $66.09 | 28.72% |
| 2023-08-02 | 14 | $141 | $32 | $77.928 | $66.09 | 17.91% |
| 2023-08-03 | 14 | $141 | $32 | $73.857 | $66.09 | 11.75% |
| 2023-08-07 | 14 | $141 | $29 | $73.642 | $66.09 | 11.43% |
| 2023-08-29 | 14 | $141 | $29 | $73 | $66.09 | 10.46% |
| 2023-09-08 | 13 | $95 | $29 | $66.857 | $66.09 | 1.16% |
| 2023-09-15 | 13 | $95 | $29 | $67.642 | $66.09 | 2.35% |
| 2023-10-06 | 13 | $95 | $38 | $71.571 | $66.09 | 8.29% |
| 2023-10-12 | 13 | $95 | $38 | $71.714 | $66.09 | 8.51% |
| 2023-10-27 | 13 | $95 | $44 | $72.142 | $66.09 | 9.16% |
| 2023-10-31 | 13 | $95 | $44 | $69.857 | $66.09 | 5.7% |
| 2023-11-03 | 14 | $95 | $42 | $68.866 | $66.09 | 4.2% |
| 2023-11-06 | 14 | $95 | $42 | $69.933 | $66.09 | 5.81% |
| 2023-11-09 | 15 | $95 | $42 | $70.187 | $66.09 | 6.2% |
| 2023-11-29 | 15 | $95 | $44 | $70.625 | $66.09 | 6.86% |
| 2023-12-01 | 15 | $95 | $44 | $71.125 | $66.09 | 7.62% |
| 2023-12-04 | 15 | $95 | $44 | $73.187 | $66.09 | 10.74% |
| 2023-12-15 | 15 | $95 | $39 | $67.625 | $66.09 | 2.32% |
| 2023-12-18 | 15 | $95 | $39 | $66.687 | $66.09 | 0.9% |
The Trend in the Analyst Price Target
Over the past 32 weeks, APLS's average price target has gone down $30.1.
APLS reports an average of 60.97% for its upside potential over the past 47 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-04-24 | 14 | 141 | 58 | 90.357 | 88.77 | 1.79% |
| 2023-05-02 | 14 | 141 | 58 | 90.357 | 83.14 | 8.68% |
| 2023-06-06 | 14 | 156 | 76 | 105.000 | 91.22 | 15.11% |
| 2023-08-29 | 13 | 95 | 29 | 66.642 | 40.65 | 63.94% |
| 2023-11-13 | 15 | 95 | 44 | 70.625 | 45.74 | 54.41% |
APLS Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.6 | 10 | 1 | 4 | 0 | 0 | 15 |
The Trend in the Broker Recommendations
Over the past 17 months, APLS's average broker recommendation rating worsened by 0.14.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- In the context of all US stocks, APELLIS PHARMACEUTICALS INC's variance in analysts' estimates is lower than -7625.6% of them.
- In the context of Pharmaceutical Products stocks, APELLIS PHARMACEUTICALS INC's number of analysts covering the stock is greater than 7233% of them.
- In the context of Pharmaceutical Products stocks, APELLIS PHARMACEUTICALS INC's average analyst price target is higher than 7058.67% of them.
- In the context of Pharmaceutical Products stocks, APELLIS PHARMACEUTICALS INC's upside potential (average analyst target price relative to current price) is higher than 1836.68% of them.
Stocks similar to APELLIS PHARMACEUTICALS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are ZLAB, RDY, and BGNE.
View All Top Stocks by Price Target
Is APLS a Buy, Hold or Sell? See the POWR Ratings now!